Literature DB >> 14614372

Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation.

John S Bradley1, Michael N Dudley, George L Drusano.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14614372     DOI： 10.1097/01.inf.0000094940.81959.14

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  31 in total

1.  Population pharmacokinetic model for gatifloxacin in pediatric patients.

Authors:  Christopher M Rubino; Edmund V Capparelli; John S Bradley; Jeffrey L Blumer; Gregory L Kearns; Michael Reed; Richard F Jacobs; Brenda Cirincione; Dennis M Grasela
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

Review 2.  Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.

Authors:  Michael E Pichichero; Michael D Reed
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

Authors:  Elisabet I Nielsen; Otto Cars; Lena E Friberg
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

Review 4.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.

Authors:  Yewei Chen; Jinmiao Lu; Min Dong; Dan Wu; Yiqing Zhu; Qin Li; Chao Chen; Zhiping Li
Journal:  Eur J Clin Pharmacol       Date:  2016-09-19       Impact factor: 2.953

6.  Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.

Authors:  Alexander A Vinks; Ronald N van Rossem; Ron A A Mathôt; Harry G M Heijerman; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.

Authors:  Michael E Pichichero; Gary V Doern; Joseph L Kuti; David P Nicolau
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

8.  Pharmacokinetic-pharmacodynamic profiling of four antimicrobials against gram-negative bacteria collected from Shenyang, China.

Authors:  Yun Zhuo Chu; Su Fei Tian; Bai Yi Chen; Hua Nian; Hong Shang; Guo Quan Sun
Journal:  BMC Infect Dis       Date:  2010-06-15       Impact factor: 3.090

9.  Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals.

Authors:  Rebecca A Keel; George G Zhanel; Sheryl Zelenitsky; David P Nicolau
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

10.  Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study.

Authors:  Dwarakanathan Ranganathan; Julie M Varghese; Robert G Fassett; Jeffrey Lipman; Vincent D'Intini; Helen Healy; Jason A Roberts
Journal:  BMC Nephrol       Date:  2009-12-16       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.